Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb.
Vascular regression occurs during limb mesenchymal cell condensation and chondrogenesis, but it is unclear whether it is required for these processes or is a secondary phenomenon without major regulatory roles. To address this issue, beads presoaked with the potent angiogenic factor vascular endothelial growth factor (VEGF) were implanted in the vicinity of the prospective digit 2 in early chick embryo wing buds and the effects on angiogenesis and digit development were determined over time. We found that VEGF treatment caused a marked local increase in blood vessel number and density. Strikingly, this was accompanied by inhibition of digit 2 development as revealed by lack of expression of chondrogenic transcription factor Sox9 and absence of Alcian blue staining. Vascular distribution and skeletal development in adjacent areas remained largely unaffected. Inhibition of digit formation and excess vascularization were both reversible upon further embryonic growth and dissipation of VEGF activity. When supernumerary digits were induced at the anterior limb margin by retinoic acid treatment, their development was also preceded by vascular regression; interestingly, cotreatment with VEGF inhibited supernumerary digit development as well. Direct exposure of limb mesenchymal cells in micromass cultures to VEGF caused no obvious effects on condensation and chondrogenesis, indicating that VEGF effects are not due to direct action on skeletal cells. Our results are the first to provide evidence that vascular regression is required for mesenchymal condensation and chondrogenesis. A model of how patterning mechanisms and vascular regression may intersect and orchestrate limb skeletogenesis is proposed.
Yin
M
M
Department of Anatomy and Histology, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania 19104-6003, USA. myin@mail.med.upenn.edu
Pacifici
M
M
D000818:Animals; D001808:Blood Vessels / Q000196:embryology*; D002358:Cartilage, Articular / Q000196:embryology*; D002642:Chick Embryo / Q000187:drug effects / Q000502:physiology; D046508:Culture Techniques; D016228:Endothelial Growth Factors / Q000494:pharmacology; D008222:Lymphokines / Q000494:pharmacology; D008648:Mesoderm / Q000187:drug effects / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014921:Wings, Animal / Q000002:abnormalities / Q000196:embryology*
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors